性酸酶的个体内波动预测死亡率和CKD进展:来自大型CKD队列的见解
Yaerim Kim1, Ping-Hsun Wu2,3,4, Soie Kwon5
1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
Clinical kidney journal
|March 11, 2026
概括
高酸酸酶 (ALP) 水平及其变异性增加慢性病 (CKD) 患者的死亡风险. 监测ALP可能会改善CKD患者的结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 生物化学 生物化学
- 临床医学 临床医学
背景情况:
- 性酸酶 (ALP) 的升高与死亡率有关.
- 慢性病 (CKD) 中ALP变异性的作用尚未得到研究.
研究的目的:
- 为了研究基线ALP,ALP变异性和慢性病患者的死亡率/末期病 (ESKD) 之间的关联.
- 评估ALP波动对CKD进展和存活率的影响.
主要方法:
- 台湾和韩国的回顾性队列研究 (2001-2021年).
- 包括患有CKD的成年人 (eGFR <60毫升/分钟/1.73米2).
- 使用考克斯模型分析了基线ALP和可变性 (SD,Cov,变异).
主要成果:
- 较高的基线ALP与增加的死亡率和ESKD风险相关.
- 较大的ALP变异性与较高的全因死亡率有显著的关联.
- 关联在诸如高血压和糖尿病等并发症中保持一致.
结论:
- 升高的ALP水平和增加的ALP变异性都是CKD死亡率的显著预测因素.
- 有针对性的ALP监测和管理可以改善CKD患者的长期结果.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
247
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
285
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
302
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
302
Chronic Kidney Disease I: Introduction
936
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
936
Chronic Kidney Disease III: Interprofessional Care
565
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
565
Chronic Kidney Disease II: Clinical Manifestations
864
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
864


